Serum concentrations of PCBs and OCPs among prepubertal Korean children

Su Hyun Park1, Young Sun Hong2, Eun-Hee Ha3

  • 1Department of Preventive Medicine, School of Medicine, Ewha Womans University, 1071, Anyangcheon-ro, Yangcheon-ku, Seoul, 158-710, Republic of Korea. shp323@ewha.ac.kr.

Insights

Children in Korea show increasing serum levels of polychlorinated biphenyls (PCBs) and organochlorine pesticides (OCPs) with age, indicating ongoing exposure despite bans. This highlights the need to understand childhood exposure to persistent organic pollutants (POPs).

Area of Science:

  • Environmental Health
  • Pediatric Toxicology
  • Analytical Chemistry

Background:

  • Children's unique physiology and behavior increase vulnerability to environmental hazards.
  • Limited research exists on internal exposure to persistent organic pollutants (POPs) in pediatric populations.
  • Assessing POPs in children is crucial for understanding long-term health risks.

Purpose of the Study:

  • To quantify serum levels of polychlorinated biphenyls (PCBs) and organochlorine pesticides (OCPs) in pre-pubertal Korean children.
  • To investigate the influence of age and gender on POPs serum concentrations.
  • To evaluate temporal changes in POPs exposure from age 7 to 9.

Main Methods:

  • Serum samples from 214 children (aged 7-9 years) were analyzed for 51 POPs.
  • Data were sourced from the Ewha Birth and Growth Cohort Study.
  • A sub-cohort (n=26) was re-tested at age 9 to track changes over time.

Main Results:

  • Median serum PCB concentration was 26.44 ng/g lipid, and OCPs was 74.82 ng/g lipid.
  • Significant age-dependent increases in total PCBs were observed (p=0.0001).
  • No significant gender differences were found for total PCBs or OCPs; strong correlations existed between individual POPs.

Conclusions:

  • Despite bans on POPs use since 2001, Korean children exhibit continued exposure.
  • Childhood POPs exposure levels were lower than in some international studies.
  • Further research is needed to identify exposure routes and risk factors for long-term, low-level POPs exposure in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
332
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
464
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
732
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
4.0K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
374